Acunetix vs ImmuniWeb comparison

"It's very user-friendly for the testing teams. It's very easy for them to understand things and to fix vulnerabilities."

"I find it to be one of the most comprehensive tools, with support for manual intervention."

"I haven't seen reporting of that level in any other tool."

"Our developers can run the attacks directly from their environments, desktops."

"Acunetix is the best service in the world. It is easy to manage. It gives a lot of information to the users to see and identify problems in their site or applications. It works very well."

"By integrating with CI/CD tools, it enables a shift-left approach in the development process."

"The most valuable feature of Acunetix is the UI and the scan results are simple."

"For us, the most valuable aspect of the solution is the log-sequence feature."

"ImmuniWeb boasts a robust vulnerability detection mechanism, formidable threat mitigation, and an efficient remediation process, incorporating automation techniques and ALM strategies. The solution is highly stable. The solution is scalable. Editing Key Points for Review "Review about ImmuniWeb" What is our primary use case? We use the solution when we face challenges and urgent attention is needed for complex cases from our clients. To address this, we collaborate with the middleware, internal, and client teams to analyze and sort through intricate logs concerning our business cybersecurity program. How has it helped my organization? The solution helped us with one of our clients in the New York area contacted us about a data breach. In response, we swiftly organized a case meeting involving our client, internal, and email customer support teams. Together, we conducted an incident response, facilitating offline assistance for proper planning and risk management processes. We delved into the details of the data breach, identified how it occurred, and collaborated to rectify the issue. The client expressed satisfaction with the resolution process. What is most valuable? ImmuniWeb boasts a robust vulnerability detection mechanism, formidable threat mitigation, and an efficient remediation process, incorporating automation techniques and ALM strategies. It also focuses on consumer satisfaction and operates in English-speaking markets, primarily required by the UAE, the United States, Canada, and Australia, among other developed countries. For how long have I used the solution? We have been using this product for the past one and half years. What do I think about the stability of the solution? The solution is highly stable. I rate it a perfect ten. What do I think about the scalability of the solution? The solution is scalable. I rate it a nine out of ten. How are customer service and support? Support is generally excellent"

"After the assessment, you clearly know which assets require penetration testing."

"ImmuniWeb is stable."

"The initial setup process is user-friendly."

"The solution's most valuable feature is reporting."

"The most valuable features are the SLA of Zero false-positives, less time of service development, validation of unlimited patched vulnerabilities, and several others."

"I like the fully automated continuous discovery run by ImmuniWeb in the background. We do not need to rerun the same tests or the same scanning against our resources. We need to supply our IP addresses, domain names, and significant resources with special domain names and URLs, and we need to do it only once. Then we always have an up-to-date picture. I also like the integration with our single sign-on system. We do not need to maintain a separate set of usernames or user accounts. We can plug this ImmuniWeb service into our authentication technology, enabling two-factor authentication. We have secure authentication right out of the box. The other important feature I like is the executive view. You can easily switch from a technical view to an executive view and have a helicopter view of the compliance status. We can see how much effort is required and our current status."

"There's a clear need for a reduction in pricing to make the service more accessible."

"We have had issues during upgrades where their scans worked on some apps better with previous versions. Then, we had to work with their tech support, who were great, to get it fixed for the next version."

"In terms of what needs improvement, the way the licensing model is currently is not very convenient for us because initially, when we bought it, the licensing model was very flexible, but now it restricts us."

"The solution can be improved by adding the ability to scan subdomains automatically, and by providing reports that can be exported to external databases to share with other solutions."

"There was an issue related to updates from the internet."

"There are some versions of the solution that are not as stable as others."

"Integration into other tools is very limited for Acunetix. While we're trying to incorporate a CI/CD process where we're integrating with JIRA and we're integrating with Jenkins and Chef, it becomes problematic. Other tools give you a high integration capability to connect into different solutions that you may already have, like JIRA."

"The only problem that they have is the price. It is a bit expensive, and you cannot change the number of applications for the whole year."

"The product’s interface for the web applications could be similar to Android and iOS versions."

"Its technical support could be better."

"ImmuniWeb sometimes shows previous scans instead of running tests."

"The deployment process on the cloud is straightforward, while on-premise can be complex. Support is generally excellent, although there can be delays in ticket resolution."

"It would be better if they had an automated tagging feature. The tagging functionality currently requires manual tagging, and that's probably the most needed feature from my standpoint. We also do not have enough tools, enough features, or options to display different resources in the way we need. There are basic grouping and some filtering features, but we still cannot fully separate some flavors of our resources. However, we may not be aware of the latest features."

"A great idea would be to support using Discovery on the internal network, allowing delivery of all the features of the current Discovery to internal network resources."

"A great idea would be to make a mobile application for the ImmuniWeb portal so that all information would be available on the go and from a mobile phone as well. It would be much more convenient."

"The costs aren't very expensive. It costs around $3000 or $4000."

"The pricing and licensing are reasonable to a point. In order to run multiple scans at a time, we are going to have to purchase a 100 count license, which is an overkill. Though, compared to what we were paying for, the cost seems reasonable."

"Implementing Acunetix needs a medium or larger business agency, because you need some money to get Acunetix. It is costly, but if you care about your agency's security, then maybe it's a cost that might help you in the future."

"When we looked at all other vendors and what they were asking for, to provide a third of what Acunetix was capable of doing, it was an easy decision... But now that it's coming to a cost where it's line with market value, it becomes more of a competition... Acunetix is raising the cost of licensing. It's 3.5 times what we were initially quoted."

"I would say that Acunetix is expensive because there are products on the market with similar features that are equally or better-priced."

"The solution is expensive."

"When compared with other products, the pricing is a little bit high. But it gives value for the price. It serves the purpose and is worthwhile for the price we pay."

"The price is exceptionally high."

"I use the product's free version. The tool costs around 229 dollars."

"It is pretty expensive."

"ImmuniWeb is relatively cheap. It's a competitive price compared to other products in the marketplace. It's worth the money we are paying for it."

"The platform is expensive if a large development is involved. However, it is less expensive for scheduled-based testing, quarterly or in a year."

"There should be the flexibility to change or add pricing, especially for pay-per-use cases."

"It is pretty expensive."

"The values of ImmuniWeb are currently significantly below what is valued in the Chilean market for these services and solutions."